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Teresina, February 28, 2017
Dear editor
Neurological symptoms of approximately two thirds of patients with Guillain-
Barré syndrome (GBS) begin a few weeks after an apparently benign febrile 
infection with respiratory or gastrointestinal manifestations1. Using serological 
methods, several studies identified as major infectious agents involved in GBS: 
Campylobacter jejuni, Mycoplasma pneumoniae, Cytomegalovirus, Epstein-Barr 
virus and Haemophilus influenzae2-5, but some flaviviruses with a documented 
circulation in Brazil were identified as triggers of GBS in the last two decades, 
especially dengue virus (DENV), West Nile virus (WNV) and Saint Louis 
encephalitis virus (SLEV)4,6-9.
The introduction of the Zika virus (ZIKV) in Brazil was laboratory confirmed in 
May 2015 in the midst of an epidemic of a mild and sub-febrile exanthematic disease 
that affected especially inhabitants of the Northeast region of the country10. The 
disease was considered by some, at that time, as a mild form of infection by DENV. 
Thus, many symptomatic human infections by ZIKV may have been reported as 
dengue cases to health authorities. A few months later, the benign character attributed 
to ZIKV infection was questioned in face of its association with an increased number 
of GBS cases, microcephaly and other congenital malformations11. The first cases 
of Zika virus infection in Piauí State were laboratory confirmed in July 2015, but 
medical records point to its significant occurrence in that State up to five months 
before12. Phylogenetic analysis and molecular clock showed that the introduction 
of ZIKV in Brazil occurred between May and December 201313. 
The local State Division of Epidemiology was already carrying out a surveillance 
program of neurological cases since the laboratory confirmation of the first West 
Nile human case in the country in August 2014, in Aroeiras do Itaim municipality 
– Piauí State – Brazil9. Since then, cases of aseptic meningitis, viral encephalitis, 
transverse myelitis and GBS have been submitted to epidemiological and laboratory 
investigation, which allowed monitoring the occurrence of these disorders12. 
Considering the State records on the occurrence of neurological diseases and 
data from the National System of Notifiable Diseases - Piauí section (SINAN-PI, 
in Portuguese), the existence of a temporal correlation between GBS time series 
and notifications of suspected cases of dengue in 2015 were verified. The cross-
correlation analysis of the time series was chosen instead of a simple linear correction 
because: (i) a gap was expected between the previous infectious syndrome and the 
onset of neurologic manifestations, and (ii) the record of suspected dengue is more 
dynamic than the occurrence of GBS due to factors related to the natural history 
of each disease and the patient’s access to a medical notifier service. Correlation 
calculations were performed using the software Bioestat 5.0® and Free Statistic 
Software v1.1.23-r7®14. 
In 2015, in Piauí State, 7,659 suspected dengue cases were reported in parallel 
with 42 cases of GBS. Serological tests (ELISA-IgM) were positive for dengue in 
23.8% of GBS cases. There were no positive results for WNV. Testing for ZIKV 
had not yet been included in the GBS case investigation panel in 2015. Distributions 
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of monthly notifications of suspected dengue and GBS 
cases in 2015 obeyed a monophasic up and down pattern, 
with the maximum occurrence reported for April and 
June, on an annualized rate of 5.5 GBS cases per 1,000 
dengue notifications (Figure 1). The cross-correlation 
analysis (Figure 2) showed the maximum parallelism 
upon assigning a delay from one (rho = +0.78, CI 95% 
= 0.36 to 0.93; p = 0.003) to two (rho = +0.86, CI 95% 
= 0.59 to 0.96; p = 0.0003) months between time series. 
The maximum correlation between the time series of GBS 
cases and suspected dengue notifications recorded in Piauí 
State (1-2 months) is consistent with the description of the 
syndrome as a post-infectious phenomenon, characterized 
by an autoimmune attack on the myelin sheath triggered by 
an antigenic stimulation a few weeks before1,4. 
It is possible that a significant proportion of notifications 
of suspected dengue cases have corresponded to the 
infection caused by ZIKV because there is great similarity 
between the clinical manifestations of these viral diseases. 
In addition, the availability of laboratory tests in Piauí 
municipalities is limited. Until the first laboratory 
confirmation of the infection caused by ZIKV in the country 
by the Ministry of Health in May 2015, the disease was 
little known by most health-care medical services and 
epidemiological surveillance teams in Piauí State. The first 
five months of 2015 concentrated 82% of dengue-suspected 
notifications in Piauí. In the same year, 22% of the 7,659 
reported cases were serologically negative for dengue, 
and only 19% of the cases were confirmed by laboratory 
testing. The remaining cases were classified by clinical and 
epidemiological criteria. All the confirmatory laboratory 
tests were carried out by ELISA-IgM on serum samples12. 
A temporal relationship has been observed between the 
occurrence of peaks in rash Zika-simile and GBS outbreaks 
in several other regions15-18. 
It is difficult to quantify accurately the occurrence 
of Zika virus disease in Brazil in 2015. The universal 
notification of disease suspicion has only been established 
by health authorities in March 2016. So far, only laboratory-
confirmed cases were reported, except for sentinel units 
deployed in some cities in the second half of 2015, when 
the epidemic had already decreased in Northeastern Brazil. 
The Ministry of Health estimates that up to 1.5 million 
Brazilians were affected by the Zika disease in 201519. 
There is a likelihood of cross-reactivity in serological tests 
used to confirm dengue cases before non-recognized ZIKV 
infections - especially in patients with a previous history 
for that disease20. Therefore, even dengue cases classified 
as confirmed are subject to questioning due to the lack of 
a molecular biology diagnostic method and a simultaneous 
serological testing for ZIKV. 
The inferences to be drawn from this study are limited. 
The proportion of dengue cases reported as suspicious in 
2015, which corresponded to infections by Zika, remains 
in fact speculative. The similarities between the clinical 
presentations of the two diseases and the possibility of 
cross-reactions to serological examinations make the 
confirmation of cases by clinical, epidemiological and 
laboratory criteria are unpredictable when a diagnostic by 
molecular biology is dismissed. Until recently, there were 
no commercial kits for diagnosing ZIKV infection in the 
country, and detection of the viral genome by large-scale 
molecular biology is still impracticable. The magnitude of 
the occurrence of GBS is much lower than that of dengue 
- this did not allow the comparison of data in the temporal 
unit of an epidemiological week. This fact, combined 
with differences between the speed of recognition, the 
reporting of dengue and GBS and the ease of access to 
adequate diagnostic services to perform them, makes the 
delay calculated at the maximum cross-correlation subject 
to rough approximations. The time of higher occurrence 
Figure 2 - Cross-correlation between the time series of dengue-
suspected cases reported monthly and hospitalizations due to 
Guillain-Barré syndrome in the state of Piauí, Brazil, 2015. The 
dashed lines indicate a 95% confidence interval. 
Figure 1 - Reported cases of dengue fever, Guillain-Barré 
syndrome and monthly rainfall in the State of Piauí in 2015. 
(Piauí State Secretary for Health, Brazilian National Institute 
of Meteorology)
Rev Inst Med Trop São Paulo. 2017;59:e22
Guillain-Barré syndrome and dengue-like disease in 2015
Page 3 of 3
of dengue in Piauí State coincides with the rainy season, 
which is also associated with more respiratory and diarrheal 
diseases, which are potentially involved in the pathogenesis 
of GBS. 
There was a correspondence between GBS time series 
and notifications of suspected dengue in Piauí State in 2015. 
The delay of up to eight weeks between the correlated time 
series is compatible with the natural history of the syndrome 
and its post-infectious nature. In the face of evidence 
that ZIKV may act as an important GBS set-off and the 
unavailability (at that time) of notification and confirmation 
instruments of prior infection with Zika virus, the results 
of this study reinforce the need for clinical, laboratory and 
epidemiological study to differentiate DENV and ZIKV 
infections, encouraging systematic studies on the etiology 
of neurological infectious diseases in different regions of 
the country.
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